Healthcare Sales & Marketing Network News: Inogen

Searching News Database: Inogen

HSMN NewsFeed - 16 Jul 2026
Lilly to Acquire AtaiBeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 2 Jul 2026
Spinogenix Appoints Professor Joseph T. Coyle, MD, Current Chair of Psychiatry and Neuroscience at Harvard Medical School, to Scientific Advisory Board
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 27 Mar 2026
Otsuka Pharmaceutical to Acquire Transcend Therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 May 2025
Spinogenix Announces FDA-Authorized Expanded Access Program for SPG302, the First Synaptic Regenerative Therapy to Treat ALS
Biopharmaceuticals Regenerative Medicine Neurology FDA

HSMN NewsFeed - 20 May 2024
Chroma Medicine Announces Appointment of Jenny Marlowe, Ph.D., as Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 May 2023
Soligenix Announces Positive Clinical Results from Compatibility Study of HyBryte(TM) in the Treatment of Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 14 Apr 2023
Soligenix Provides Regulatory Update on HyBryte(TM)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 14 Feb 2023
Soligenix Receives Refusal to File Letter from U.S. FDA for HyBryte(TM) New Drug Application in the Treatment of Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 8 Feb 2023
CoolHealth Enters U.S. Market With TargetCool(TM), A Breakthrough FDA-Class II Medical Device Offering Unprecedented Precise, Rapid Cooling For Pain Management And Bruise Minimization
Devices Dermatology Product Launch

HSMN NewsFeed - 29 Apr 2022
OncoSec Appoints Dr. Robert Arch as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 17 Dec 2021
OncoSec Announces Changes to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Sep 2021
Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 6 Jul 2021
Delix Therapeutics Expands Executive Leadership Team
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 14 Apr 2021
OncoSec Receives CE Mark Certification for its Commercial Electroporation Device "GenPulse(TM)" for the Treatment of Solid Tumors
Devices Oncology Regulatory

HSMN NewsFeed - 11 Mar 2021
Revolutionary Option for Medical Device Sterilization Approved by FDA
Devices FDA

HSMN NewsFeed - 18 Feb 2021
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 2 Feb 2021
OncoSec Strengthens Management Team With Two New Appointments
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 12 Oct 2020
OncoSec Announces Appointment of Sandra Aung, Ph.D. as Senior Vice President, Chief Clinical Development Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 14 Aug 2020
Lupin Presents Phase 3 Data for Solosec(R) (secnidazole) Demonstrating Significant Response Rate in Female Patients with Trichomoniasis
Biopharmaceuticals

HSMN NewsFeed - 30 Jun 2020
Respira Technologies, Inc. announces Brian W. Quigley, former CEO of Altria Group's Smokeless Division, to join as Chief Operating Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 30 Apr 2020
Soligenix Announces Positive Phase 3 FLASH Study Demonstrates Increased Efficacy with Continued Treatment in Patients with Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Apr 2020
MindMed Promotes Jeanne Bonelle to Executive Vice President, Technical Operations
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 12 Mar 2020
Leading Psychedelic Pharmaceutical Company MindMed Forms New Board Committee To Evaluate Acquisitions And Scientific Collaborations
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 27 Jun 2019
OncoSec Receives Exclusive Licensing Rights from Dana-Farber Cancer Institute to CAR T-Cell Therapies for the Treatment of Solid Tumor Cancers
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 24 Apr 2019
OncoSec Appoints Industry Veteran Margaret R. Dalesandro, Ph.D., to its Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 10 Apr 2019
OncoSec Announces New Technology to Treat Deep Visceral Lesions with IL-12
Biopharmaceuticals Oncology Drug Delivery

HSMN NewsFeed - 1 Apr 2019
OncoSec Announces Advanced Therapy Medicinal Product Classification from the EMA for TAVO(TM) in Refractory Metastatic Melanoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 29 Jan 2019
ViaCyte Announces New Board Members
Regenerative Medicine Personnel

HSMN NewsFeed - 21 Dec 2018
OncoSec Announces Appointment Of Joon Kim, J.D., To Board Of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 8 Nov 2018
OncoSec Appoints Robert Ward to its Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 29 Oct 2018
OncoSec Appoints Kellie Malloy Foerter as Chief Clinical Development Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 26 Sep 2018
Aronora's New Blood Clot Treatment Receives FDA Fast Track Designation
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Sep 2018
FDA Approves CroFab(R) Product Improvements
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Sep 2018
OncoSec Announces $15 Million At Market Investment from Alpha Holdings, Inc.
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 28 Aug 2018
OncoSec Appoints Alain Algazi, MD, as Clinical Strategic Advisor
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 30 Jul 2018
OncoSec Appoints Robert W. Ashworth, Ph.D. as Vice President, Regulatory
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 19 Jul 2018
BioPharmX Announces FDA Grant of CARC Waiver and Post-Hoc Analysis for BPX-01
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 21 May 2018
CERENOVUS Receives FDA Clearance For Next Generation Stent Retriever Device Used To Treat Ischemic Stroke
Devices Interventional Radiology Neurology FDA

HSMN NewsFeed - 12 Dec 2017
Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia
Biopharmaceuticals Cardiology Licensing

HSMN NewsFeed - 6 Dec 2017
Sirnaomics' Leading siRNA Therapeutic Candidate, STP705, Granted Orphan Designation for Treatment of Cholangiocarcinoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 5 Dec 2017
OncoSec Announces Promotion of Christopher G. Twitty, Ph.D. to Chief Scientific Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 19 Oct 2017
OncoSec Presents Positive Phase 2 Data for ImmunoPulse(R) IL-12 in Combination with Pembrolizumab Demonstrating a Best Overall Response Rate (BORR) of 50% in Predicted Anti-PD-1 Non-Responder Melanoma Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 Sep 2017
Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate(TM) Devices with the HeartLogic(TM) Heart Failure Diagnostic
Devices Cardiology FDA

HSMN NewsFeed - 11 Jul 2017
Prometic Announces Positive Long Term Clinical Data on Ryplazym(TM) in Plasminogen Congenital Deficiency and Provides Regulatory Update
Biopharmaceuticals

HSMN NewsFeed - 6 Dec 2016
Inogen Announces Management Transitions and Expanded Board of Directors
Devices Personnel

HSMN NewsFeed - 19 Oct 2016
SELLAS(TM) Life Sciences Appoints Former Barclays Biotechnology Research Analyst as Chief Business and Strategy Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 7 Jul 2016
Shire Receives Extension of Market Authorization in Europe for Revestive(R) (Teduglutide) for the Treatment of Paediatric Patients with Short Bowel Syndrome (SBS)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 23 Feb 2016
Boston Scientific Receives U.S. FDA Approval For Quadripolar Leads And Initiates Global Trial To Expand MRI Labeling To The U.S. And Asia
Devices Cardiology FDA

HSMN NewsFeed - 1 Feb 2016
Mallinckrodt Completes Acquisition Of Three Commercial-Stage, Global Specialty Hemostasis Brands From The Medicines Company
Devices Surgery Acquisitions

HSMN NewsFeed - 29 Jan 2016
Allergan's Rapastinel Receives FDA Breakthrough Therapy Designation for Adjunctive Treatment of Major Depressive Disorder (MDD)
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 8 Dec 2015
Inogen Releases Enhanced Inogen One G3 Oxygen Concentrator
Devices Product Launch

HSMN NewsFeed - 19 Nov 2015
Calimmune Expands Board of Directors, Names R. Scott Greer as Chairman
Biopharmaceuticals HIV/AIDS Personnel

HSMN NewsFeed - 4 Nov 2015
Vaccinogen Promotes Peter Morsing, Ph.D. to Chief Operating Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 6 Apr 2015
FDA Expands Indication for EVARREST(R) Fibrin Sealant Patch
Devices Surgery FDA

HSMN NewsFeed - 30 Mar 2015
The Medicines Company Receives European Commission Approval for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(R) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 3 Feb 2015
U.S. FDA Grants Priority Review for YONDELIS(R) (trabectedin) for the Treatment of Patients with Advanced Soft Tissue Sarcoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 Jan 2015
The Medicines Company Receives CHMP Positive Opinions for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(TM) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 25 Aug 2014
Vaccinogen Completes Initial Closing of an $80 Million Financing
Biopharmaceuticlas Oncology Venture Capital

HSMN NewsFeed - 22 May 2014
Third Rock Ventures and The Column Group Launch Nurix with $25.1 Million Financing to Target Key Regulatory Pathway
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 12 May 2014
FDA Approves ZONTIVITY(TM) (vorapaxar), First-in-Class PAR-1 Antagonist, for the Reduction of Thrombotic Cardiovascular Events in Patients with a History of Heart Attack or with Peripheral Arterial Disease
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 23 Apr 2014
The Medicines Company Adds Novel, Approved, Surgical Sealant to Its Surgical Hemostasis Portfolio
Devices Surgery Mergers & Acquisitions

HSMN NewsFeed - 24 Mar 2014
BEAT BioTherapeutics Appoints Dr. Sam L. Teichman as Chief Medical Officer
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 20 Jan 2014
Pulmonary Embolism Trial Comparing Endovascular Ultrasound to Standard of Care Anticoagulation Published in the American Heart Association’s Journal, Circulation
Devices Interventional

HSMN NewsFeed - 17 Dec 2013
Boston Scientific Announces CE Mark Approval And First Implants Of Its Next-Generation X4 Quadripolar CRT-D Systems
Devices Cardiology Regulatory

HSMN NewsFeed - 5 Dec 2013
Inogen Releases Improved Inogen One G2 Oxygen Concentrator
Devices Product Launch

HSMN NewsFeed - 23 Jul 2013
XenoPort Announces Inclusion of Horizant (Gabapentin Enacarbil) in Guidelines for Long-Term Treatment of Restless Legs Syndrome/Willis-Ekbom Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 23 Jul 2013
Instrumentation Laboratory Launches HemosIL(R) FDP Assay In Europe, Asia And Other International Regions
Diagnostics Product Launch

HSMN NewsFeed - 4 Jun 2013
The Medicines Company Signs Agreement to Acquire ProFibrix
Biopharmaceuticals Surgery Mergers & Acquisitions

HSMN NewsFeed - 14 Jan 2013
Covidien Opens Patient Enrollment for SWIFT PRIME Acute Ischemic Stroke Study
Devices Neurology Interventional

HSMN NewsFeed - 9 Jan 2013
Spinomix Closes a $ 3 Million Financing Round Led by Debiopharm Group
Diagnostics Venture Capital

HSMN NewsFeed - 7 Dec 2012
FDA Approves EVARREST(TM) Fibrin Sealant Patch
Devices Surgery FDA

HSMN NewsFeed - 28 Nov 2012
Smith & Nephew Announces Agreement To Acquire Assets Of Healthpoint Biotherapeutics
Biopharmaceuticals Wound Care Orthopaedic Acquisitions

HSMN NewsFeed - 31 Oct 2012
Abaxis Announces Exclusive Distribution Agreement with Abbott
Diagnostics Distribution

HSMN NewsFeed - 27 Mar 2012
InterMune Appoints Mr. Jean-Jacques Bienaime and Dr. Frank Verwiel to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Mar 2012
CSL Behring Announces First Patient Treated in Phase III Study of Fibrinogen Concentrate (Human)(FCH) to Control Bleeding During Aortic Aneurysm Surgery
Biopharmaceuticals Surgery

HSMN NewsFeed - 23 Jan 2012
EpiCept Corporation Receives Finalized FDA Guidance for AmiKet(TM) Phase III CIPN Program and Regulatory Strategy
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Jan 2012
Insmed Incorporated Provides Corporate Update
Biopharmaceuticals

HSMN NewsFeed - 19 Dec 2011
Cerevast Therapeutics Receives CE Mark for Clotbust ER™ Ultrasound Stroke Treatment Device
Devices Neurology Regulatory

HSMN NewsFeed - 31 Mar 2011
VICTRELIS(TM) (boceprevir), Merck's Investigational Medicine, Added to Peginterferon Alfa-2a and Ribavirin Achieved Significantly Higher SVR Rates In Treatment-Failure Patients with Chronic HCV Genotype 1 Compared to Control
Biopharmaceuticals

HSMN NewsFeed - 20 Jan 2011
Radient Pharmaceuticals Receives Updated European Union Certification for Onko-Sure(R); CE Mark Opens Large Market for Company's IVD Cancer Test
Diagnostics Regulatory

HSMN NewsFeed - 15 Nov 2010
Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development
Biopharmaceuticals Devices Interventional Cardiology

HSMN NewsFeed - 13 Oct 2010
Radient Pharmaceuticals and Provista Life Sciences Announce New Blood Test for Lung Cancer
Diagnostics Oncology

HSMN NewsFeed - 23 Sep 2010
Portola Pharmaceuticals Appoints Jean-Jacques Bienaime to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jul 2010
Radient Pharmaceuticals Announces Exclusive Distribution Agreement With AMDL Australia Pty Ltd.
Biopharmaceuticals Diagnostics Distribution

HSMN NewsFeed - 30 Jun 2010
Raptor Pharmaceutical Announces License Agreement for Convivia(TM)
Biopharmaceuticals Licensing

HSMN NewsFeed - 26 Jan 2010
Cardium Provides Update on Commercial Development Plans for Generx Angiogenic Therapy for Heart Disease at 2010 Cell & Gene Therapy Forum
Biopharmaceuticals Cardiology Regenerative Medicine

HSMN NewsFeed - 31 Dec 2009
Photocure Received Positive Response From FDA on the New Drug Application (NDA) for Hexvix(R) for Detection of Bladder Cancer
Biopharmaceuticals Diagnostics Oncology FDA

HSMN NewsFeed - 7 Dec 2009
Somaxon Receives Complete Response Letter from the FDA for Silenor(R) NDA
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Nov 2009
EKOS Corporation Launches the New EkoSonic(TM) MACH4e at VEITHsymposium in New York
Devices Interventional

HSMN NewsFeed - 5 Oct 2009
FDA Advisory Committee Recommends Approval of PEGINTRON(R) for the Adjuvant Treatment of Stage III Malignant Melanoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 31 Aug 2009
FDA Approves Valcyte(R) (valganciclovir hydrochloride) to Prevent Cytomegalovirus (CMV) Disease in Pediatric Patients Who Receive Heart or Kidney Transplants
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Aug 2009
ProFibrix Raises US $11 Million (EUR 8 million) in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 9 Jun 2009
Talecris Biotherapeutics Receives Orphan Drug Designation for Plasmin (Human) to Treat Acute Peripheral Arterial Occlusion
Biopharmaceuticals FDA

HSMN NewsFeed - 20 May 2009
Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 7 May 2009
Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
Biopharmaceuticals Wound Care

HSMN NewsFeed - 2 Apr 2009
Xanodyne's New Drug Application for the Treatment of Heavy Menstrual Bleeding (Menorrhagia) Accepted for Filing with a Priority Review Classification
Biopharmaceuticals FDA

HSMN NewsFeed - 31 Mar 2009
Cardium's InnerCool Announces Journal of Neurotrauma Highlights Hypothermia Therapy's Role in Post Cardiac Arrest, and Traumatic Brain and Spinal Cord Injury Patients
Devices Neurosurgery

HSMN NewsFeed - 20 Mar 2009
Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date
Biopharmaceuticals Cardiology

HSMN NewsFeed - 11 Mar 2009
FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Mar 2009
CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Mar 2009
Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
Devices Urology Oncology

HSMN NewsFeed - 20 Feb 2009
Results of NeuroThera Effectiveness and Safety Trial - 2 (NEST-2) Presented at International Stroke Conference 2009
Devices Neurology

HSMN NewsFeed - 13 Feb 2009
IMPACT Study Demonstrates That Longer Prophylactic Therapy With Valcyte(R) (Valganciclovir Hydrochloride Tablets) Increases Protection Against CMV - the Most Serious Viral Infection Affecting Transplant Patients
Biopharmaceuticals

HSMN NewsFeed - 13 Feb 2009
Haemacure Restructures - Seeks Financing or Sale of the Company
Biopharmaceuticals Devices Surgery Wound Care

HSMN NewsFeed - 27 Jan 2009
Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
Biopharmaceuticals

HSMN NewsFeed - 17 Jan 2009
CSL Behring Receives FDA Approval of RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Dec 2008
Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study
Devices Urology

HSMN NewsFeed - 15 Dec 2008
Cardium's InnerCool Awarded U.S. Supplier Agreement With Novation LLC
Devices Group Purchasing

HSMN NewsFeed - 24 Nov 2008
Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 11 Nov 2008
Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
Devices Urology

HSMN NewsFeed - 20 Oct 2008
Cardium Announces FDA 510(K) Clearance of InnerCool's RapidBlue(TM) Endovascular System
Devices FDA

HSMN NewsFeed - 25 Sep 2008
Recent Research Shows Significant Benefits in Acute Ischaemic Stroke With Actilyse(R) Beyond Currently Approved Three Hour Treatment Window
Biopharmaceuticals Neurology

HSMN NewsFeed - 18 Sep 2008
ProFibrix Expands Management Team and Opens US Subsidiary
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Aug 2008
Avantis Medical Systems, Inc. Announces Key Leadership Appointments
Devices Personnel

HSMN NewsFeed - 18 Aug 2008
Somaxon Pharmaceuticals Announces the Appointment of Senior Commercial Leadership
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Aug 2008
U.S. Food and Drug Administration Approves Viread(R) for Chronic Hepatitis B in Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Aug 2008
Somaxon Pharmaceuticals Appoints Richard W. Pascoe as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jul 2008
Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
Devices Regulatory

HSMN NewsFeed - 6 Jun 2008
Inspire Announces Achievement of Primary Endpoint in Phase 3 Trial with Denufosol for Cystic Fibrosis
Biopharmaceuticals

HSMN NewsFeed - 21 May 2008
Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
Biopharmaceuticals

HSMN NewsFeed - 1 May 2008
Coversyl(R) Protects Hypertensive Patients Against New-Onset Diabetes
Biopharmaceuticals

HSMN NewsFeed - 29 Apr 2008
Cardium Reports on Science Channel Series Featuring InnerCool's Endovascular Cooling During Brain Surgery at Stanford University
Devices Neurosurgery

HSMN NewsFeed - 25 Apr 2008
FDA Provides Clarity to Isis Regarding the Development Path for Mipomersen
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Apr 2008
Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
Biopharmaceuticals

HSMN NewsFeed - 15 Apr 2008
Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
Devices Cardiology

HSMN NewsFeed - 10 Apr 2008
MannKind Addresses Pfizer's Announcement Regarding Exubera
Biopharmaceuticals Drug Delivery Endocrinology Oncology

HSMN NewsFeed - 27 Mar 2008
Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Mar 2008
Novel Oral Anticoagulant Pradaxa(R) (dabigatran etexilate) Approved by the European Commission
Biopharmaceuticals Regulatory

HSMN NewsFeed - 20 Mar 2008
Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
Devices FDA

HSMN NewsFeed - 19 Mar 2008
Cardium's InnerCool Therapies Unit Announces Australian Distribution Agreement for CoolBlue and Rapid Blue Systems
Devices Distribution

HSMN NewsFeed - 11 Feb 2008
Cancer Pioneer Reaches Key Agreement on Colon Cancer Drug OncoVAX(R)
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 11 Feb 2008
ACAAI Publishes New Supplement on Hereditary Angioedema
Biopharmaceuticals

HSMN NewsFeed - 31 Jan 2008
Somaxon Pharmaceuticals Submits New Drug Application for SILENOR(TM) for the Treatment of Insomnia
Biopharmaceuticals

HSMN NewsFeed - 28 Jan 2008
BioMarin Appoints Dr. Gordon Vehar, Vice President of Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jan 2008
Roche responds to announcement of 'IDEAL' hepatitis C trial results
Biopharmaceuticals

HSMN NewsFeed - 4 Jan 2008
ImaRx Provides Update on TUCSON Phase I/II Clinical Trial in Acute Ischemic Stroke
Biopharmaceuticals Neurology

HSMN NewsFeed - 15 Nov 2007
PEGINTRON(TM) and REBETOL(R) Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non-Pegylated Interferon Therapy
Biopharmaceuticals Regulatory

HSMN NewsFeed - 14 Nov 2007
Cardium and InnerCool Complete $5 Million Commercial Financing to Support Launch of New Product Lines
Devices

HSMN NewsFeed - 12 Nov 2007
PAION is Seeking a New US-Partner for Desmoteplase
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 Nov 2007
Treatment with PEGASYS(R)/COPEGUS(TM) Provides Hope for Hepatitis C Patients Whose Infection Did Not Initially Respond to Peg-Intron(R)/Ribavirin
Biopharmaceuticals

HSMN NewsFeed - 2 Nov 2007
Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
Biopharmacetuicals

HSMN NewsFeed - 30 Oct 2007
Significant New Data on Roche's PEGASYS(R) and Hepatitis C Pipeline Compounds to be Featured at 58th Annual AASLD Meeting
Biopharmaceuticals

HSMN NewsFeed - 22 Oct 2007
InnerCool Licenses New Therapeutic for Potential Use in Stroke Patients
Devices Biopharmaceuticals Cardiology Licensing

HSMN NewsFeed - 8 Oct 2007
Anaptys Biosciences Appoints R. Scott Greer to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Sep 2007
European Union's CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
Biopharmaceuticals Regulatory

HSMN NewsFeed - 11 Sep 2007
Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
Biopharmaceuticals

HSMN NewsFeed - 31 Jul 2007
New Study Finds Tindamax(R) to be Effective, Well-Tolerated Treatment for Bacterial Vaginosis
Biopharmaceuticals

HSMN NewsFeed - 30 Jul 2007
ThermoGenesis Corp. Obtains FDA Clearance to Market CryoSeal(R) Fibrin Sealant (FS) in Liver Resection Surgeries
Devices FDA Surgery

HSMN NewsFeed - 24 Jul 2007
CoAxia(TM) Announces First Use of NeuroFlo(TM) Technology in Study for Stroke Patients After Attempted Thrombolysis
Devices Neurology Interventional

HSMN NewsFeed - 18 Jul 2007
FDA Grants Fast Track Designation to Cardium's Phase 3 Angiogenic Gene Therapy for Heart Disease
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 6 Jul 2007
OMRIX Biopharmaceuticals Receives Food and Drug Administration (FDA) Approval to Use Cryoprecipitate from Talecris Biotherapeutics, Inc. in Its Manufacturing Process
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Jul 2007
Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 Jun 2007
GSK and Adolor Update Alvimopan (Entereg/Entrareg(R)) Development Program
Biopharmaceuticals

HSMN NewsFeed - 31 May 2007
Topline Results of Phase III Study in Acute Ischemic Stroke (Dias-2) Do Not Demonstrate Difference Between Desmoteplase and Placebo
Biopharmaceuticals Neurology

HSMN NewsFeed - 28 May 2007
Perceptronix Brings Early Lung Cancer Detection to UK By Signing Service Agreement With University Hospital of Coventry and Warwickshire NHS Trust
Diagnostics Oncology

HSMN NewsFeed - 24 May 2007
FDA Approves Tindamax(R) for Bacterial Vaginosis
Biopharmaceuticals FDA

HSMN NewsFeed - 9 May 2007
Somaxon Pharmaceuticals Provides Update on SILENOR(TM) Development Program
Biopharmaceuticals

HSMN NewsFeed - 18 Apr 2007
Imaging Diagnostic Systems' Director of Clinical Research Cautions Against Excess Radiation Dose to Breasts
Devices Radiology Oncology

HSMN NewsFeed - 18 Apr 2007
ONCONASE(R) has Potential as Chemopreventive Agent in Mesothelioma, Reports World-Renowned Mesothelioma Researcher at AACR Annual Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Mar 2007
Siemens Medical Solutions Diagnostics' Clinitek Advantus Analyzer Delivers the Next Generation of Urinalysis Testing Technology
Diagnostics Devices

HSMN NewsFeed - 22 Mar 2007
First Patient Enrolled in RAPID MI-ICE Study Employing InnerCool's Endovascular Temperature Modulation Therapy for Heart Attack
Devices Cardiology

HSMN NewsFeed - 20 Mar 2007
Talecris Initiates Clinical Development Program Evaluating Plasmin for Dissolving Blood Clots and Restoring Blood Flow in Legs
Biopharmaceuticals

HSMN NewsFeed - 5 Feb 2007
Cardium and InnerCool Announce New External and Internal Patient Temperature Modulation Systems
Devices

HSMN NewsFeed - 17 Jan 2007
bioMerieux Licenses Technology From Norchip to Launch a HPV Test For Cervical Cancer Risk Detection
Diagnostics Oncology Licensing

HSMN NewsFeed - 12 Jan 2007
Catalyst Pharmaceutical Partners, Inc. Adds Thomas Kosten, M.D. to Its Scientific Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Dec 2006
Somaxon's SILENOR(TM) Demonstrates Positive Results in Long-Term Phase 3 Clinical Trial in Elderly Patients with Insomnia
Biopharmaceuticals

HSMN NewsFeed - 7 Dec 2006
Cardium's Generx Advances to Phase 3 Following Meeting With FDA
Biopharmaceuticals Cardiology

HSMN NewsFeed - 30 Nov 2006
Cardium Announces Formation of Scientific Advisory Board
Devices Personnel

HSMN NewsFeed - 20 Nov 2006
Somaxon Pharmaceuticals' SILENOR(TM) Demonstrates Positive Results in Its Third Phase 3 Clinical Trial in Insomnia
Biopharmaceuticals

HSMN NewsFeed - 13 Nov 2006
Treatment of Diabetic Foot Ulcers to Be Addressed at Upcoming American Heart Association Meeting
Biopharmaceuticals Wound Care

HSMN NewsFeed - 9 Nov 2006
Neurobiological Technologies, Inc. Comments on Recent Stroke Trial Developments
Biopharmaceuticals Neurology

HSMN NewsFeed - 1 Nov 2006
Inspire and FAES Farma Announce Licensing Agreement for New Oral Antihistamine to Target Allergy Market in United States and Canada
Biopharmaceuticals LIcensing

HSMN NewsFeed - 1 Nov 2006
MediciNova Announces the Acquisition of Two Novel Antithrombotic Agents from Meiji Seika Kaisha, Ltd.
Biopharmaceuticals Cardiology Acquisitions

HSMN NewsFeed - 28 Oct 2006
Patient Recruitment to Resume Without Modification of Protocol for Desmoteplase Phase IIB/III Stroke Study DIAS-2
Biopharmaceuticals Neurology

HSMN NewsFeed - 24 Oct 2006
Cardium Reports on Positive Effects of Hypothermia Following Heart Attack and Announces Clinical Study to Be Co-Sponsored by Swedish Cardiology Center
Devices Interventional Cardiology

HSMN NewsFeed - 23 Oct 2006
Somaxon Pharmaceuticals' SILENOR(TM) Demonstrates Positive Results in a Phase 3 Transient Insomnia Clinical Trial
Biopharmaceuticals

HSMN NewsFeed - 10 Oct 2006
DOV Pharmaceutical, Inc. Announces New Strategic Direction, Bicifadine Clinical Studies Results and Program Updates
Biopharmaceuticals

HSMN NewsFeed - 21 Sep 2006
Dr. Michael Morgan Reports on Benefits of InnerCool's Celsius Control System in Inducing Hypothermia During Aneurysm Surgery
Devices Neurosurgery

HSMN NewsFeed - 19 Jul 2006
Somaxon Pharmaceuticals Provides Update on SILENOR(TM) Development Program for the Treatment of Insomnia
Biopharmaceuticals

HSMN NewsFeed - 26 Jun 2006
Enrollment in Phase III Clinical Trial for OMRIX's Thrombin Stand-Alone Product Has Been Completed
Biopharmaceuticals

HSMN NewsFeed - 1 Jun 2006
Dr. Gabor Rubanyi of Berlex Biosciences Joins Cardium as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 May 2006
Alfacell Corporation To Launch New Program to Explore Potential of ONCONASE(R) to Prevent Mesothelioma
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 May 2006
Federal Appeals Court Rules in Cardium's Favor Over Boston Scientific and Arch Development on Patents for the Treatment of Heart Disease
Devices Cardiology Litigation

Return to NewsFeed

Additional items found! 99

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 99 additional stories matching:
Inogen
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!